Study on treatment after complete resection of high risk gastrointestinal stromal tumor (GIST)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 21 Jun 2017
At a glance
- Drugs Imatinib (Primary) ; Antineoplastics
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- Acronyms STAR ReGISTry
- 16 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 16 Dec 2016 Planned End Date changed from 31 Dec 2017 to 31 Dec 2019.
- 07 Jun 2016 Results (n=541) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology